ArticleJournal of Parkinson's disease2026
Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations.
R B Schneider et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.